Studies: New type of osteoporosis drug cuts fracture risk in women, men in cancer treatment

(5 stars)
Excellent report that tempered the promising results by projecting potential annual cost estimates of the drug at $10,000, discussing harms, and pointing out the drugmaker’s role in the study.